129 related articles for article (PubMed ID: 21083345)
1. Assessment of DBS technology for the detection of therapeutic antibodies.
Prince PJ; Matsuda KC; Retter M; Scott G
Bioanalysis; 2010 Aug; 2(8):1449-60. PubMed ID: 21083345
[TBL] [Abstract][Full Text] [Related]
2. Exploring the feasibility of using the DBS technique for metabolite radioprofiling.
Wang L; Zeng Z; Emmons G
Bioanalysis; 2010 Aug; 2(8):1365-71. PubMed ID: 21083337
[TBL] [Abstract][Full Text] [Related]
3. Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS.
Youhnovski N; Michon J; Latour S; Mess JN; Bergeron A; Furtado M; Rufiange M; Guibord P; Lefebvre M; Macarthur RB; Garofolo F
Bioanalysis; 2010 Aug; 2(8):1501-13. PubMed ID: 21083350
[TBL] [Abstract][Full Text] [Related]
4. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors.
D'Arienzo CJ; Ji QC; Discenza L; Cornelius G; Hynes J; Cornelius L; Santella JB; Olah T
Bioanalysis; 2010 Aug; 2(8):1415-22. PubMed ID: 21083342
[TBL] [Abstract][Full Text] [Related]
5. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.
Turpin PE; Burnett JE; Goodwin L; Foster A; Barfield M
Bioanalysis; 2010 Aug; 2(8):1489-99. PubMed ID: 21083349
[TBL] [Abstract][Full Text] [Related]
6. Measurement of in vivo therapeutic mAb concentrations: comparison of conventional serum/plasma collection and analysis to dried blood spot sampling.
Matsuda KC; Hall C; Baker-Lee C; Soto M; Scott G; Prince PJ; Retter MW
Bioanalysis; 2013 Aug; 5(16):1979-90. PubMed ID: 23937133
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic considerations as to when to use dried blood spot sampling.
Emmons G; Rowland M
Bioanalysis; 2010 Nov; 2(11):1791-6. PubMed ID: 21083484
[TBL] [Abstract][Full Text] [Related]
8. Evaluating and defining sample preparation procedures for DBS LC-MS/MS assays.
Liu G; Patrone L; Snapp HM; Batog A; Valentine J; Cosma G; Tymiak A; Ji QC; Arnold ME
Bioanalysis; 2010 Aug; 2(8):1405-14. PubMed ID: 21083341
[TBL] [Abstract][Full Text] [Related]
9. Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots.
Heinig K; Bucheli F; Hartenbach R; Gajate-Perez A
Bioanalysis; 2010 Aug; 2(8):1423-35. PubMed ID: 21083343
[TBL] [Abstract][Full Text] [Related]
10. Human DBS sampling with LC-MS/MS for enantioselective determination of metoprolol and its metabolite O-desmethyl metoprolol.
Liang X; Jiang H; Chen X
Bioanalysis; 2010 Aug; 2(8):1437-48. PubMed ID: 21083344
[TBL] [Abstract][Full Text] [Related]
11. Validation of a high-sensitivity assay for zatebradine in dried blood spots of human blood at pg/ml concentrations using HILIC-MS/MS.
Michi M; Ferrari L
Bioanalysis; 2010 Nov; 2(11):1863-71. PubMed ID: 21083494
[TBL] [Abstract][Full Text] [Related]
12. Utilization of dried blood spots within drug discovery: modification of a standard DiLab(®) AccuSampler(®) to facilitate automatic dried blood spot sampling.
Clark GT; Giddens G; Burrows L; Strand C
Lab Anim; 2011 Apr; 45(2):124-6. PubMed ID: 21355022
[TBL] [Abstract][Full Text] [Related]
13. Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS.
Kehler JR; Bowen CL; Boram SL; Evans CA
Bioanalysis; 2010 Aug; 2(8):1461-8. PubMed ID: 21083346
[TBL] [Abstract][Full Text] [Related]
14. Commercial enzyme immunoassay adapted for the detection of antibodies to hepatitis C virus in dried blood spots.
Croom HA; Richards KM; Best SJ; Francis BH; Johnson EI; Dax EM; Wilson KM
J Clin Virol; 2006 May; 36(1):68-71. PubMed ID: 16426889
[TBL] [Abstract][Full Text] [Related]
15. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S
Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351
[TBL] [Abstract][Full Text] [Related]
16. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method.
Spooner N; Lad R; Barfield M
Anal Chem; 2009 Feb; 81(4):1557-63. PubMed ID: 19154107
[TBL] [Abstract][Full Text] [Related]
17. Determination of oseltamivir (Tamiflu®) and oseltamivir carboxylate in dried blood spots using offline or online extraction.
Heinig K; Wirz T; Bucheli F; Gajate-Perez A
Bioanalysis; 2011 Feb; 3(4):421-37. PubMed ID: 21338262
[TBL] [Abstract][Full Text] [Related]
18. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods.
Abu-Rabie P; Spooner N
Bioanalysis; 2010 Aug; 2(8):1373-84. PubMed ID: 21083338
[TBL] [Abstract][Full Text] [Related]
19. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds.
Bowen CL; Hemberger MD; Kehler JR; Evans CA
Bioanalysis; 2010 Nov; 2(11):1823-8. PubMed ID: 21083490
[TBL] [Abstract][Full Text] [Related]
20. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs.
Denniff P; Spooner N
Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
